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Background: The present study was investigated to conﬁrm the antiobesity effect of kimchi in high-fat
diet-induced obese C57BL/6 mice.
Methods: Mice in the high-fat diet (HFD) group, standardized kimchi (S-Kimchi) group, and Korean
commercial kimchi (D-Kimchi) group, but not in the normal-diet group, were fed a high-fat diet (HFD) for
the ﬁrst 4 weeks to induce obesity. From the 5th to 8th weeks, the S- and D-Kimchi groups were fed an
HFD containing 10% of S-Kimchi or D-Kimchi, respectively. After 8 weeks, mice were sacriﬁced and
obesity-related factors were determined.
Results: Body and adipose tissue weights were signiﬁcantly lower in the kimchi-treated groups than in
the HFD group. In particular, in the D-Kimchi group, serum levels of triglyceride, total cholesterol, low-
density lipoprotein-cholesterol, insulin, and leptin were signiﬁcantly lower, and serum levels of high-
density lipoprotein-cholesterol and adiponectin were markedly higher than those in the HFD group.
Moreover, hepatic mRNA expression of adipogenesis-related genes (CCAAT/enhance-binding protein-a,
peroxisome proliferator-activated receptor-g, sterol regulatory element-binding protein-1c, and fatty
acid synthase) in the kimchi-treated groups were lower than those in the HFD group, but fatty acid
oxidation-related carnitine palmitoyltransferase-1 expressions were higher. In addition, kimchi
decreased the mRNA levels of the inﬂammation-related monocyte chemotactic protein-1 and
interleukin-6 in epididymal fat tissue.
Conclusion: Administration of kimchi, especially of D-Kimchi, which contained Leuconostoc mesenteroides
DRC 0211 starter and other subingredients, exhibited antiobesity activity by reducing body weight gains
and adipose tissue weights; modulating serum lipid proﬁles and hepatic lipogenesis; regulating serum
insulin, leptin, and adiponectin levels; and reducing adipocyte size and inﬂammatory response in
epididymal fat tissues.
Copyright © 2015, Korea Food Research Institute, Published by Elsevier. This is an open access article
under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).1. Introduction
Kimchi is a traditional Korean fermented vegetable food pre-
pared with baechu cabbage and other beneﬁcial subingredients by
lactic acid bacterial fermentation at a low temperature (4C) [1].
Kimchi is low in calories (~18 kcal/100 g) and contains high levels of
vitamins (such as vitamins A, C, B complex, K, and others), b-
carotene, minerals (such as Na, Ca, K, Fe, and P), dietary ﬁber, andience and Nutrition, Pusan
umjeong-gu, Busan 609-735,
.
titute, Published by Elsevier. This isfunctional phytochemicals (such as benzyl isothiocyanate, indoles,
thiocyanates, and sitosterols) that promote human health [1].
Many authors have reported that kimchi has beneﬁcial proper-
ties, which include antimutagenic [2], anticancer [3], antioxidant
[4], antiaging [5], antiatherogenic [6], and antidiabetic [7] activities,
and ﬁbrinolytic effects [8]. Furthermore, many studies have
demonstrated the antiobesity effect of kimchi in animals [9,10] and
humans [11]. Recently, it was reported that subingredients can
improve the health beneﬁts of kimchi [12,13], and that the inocu-
lation of a pure culture starter, with Weissella koreensis or Leuco-
nostoc (Leu.) citreum, increases the antiobesity effects of kimchi in
high-fat diet-induced obese (DIO) mice [9], and improves the
shelf life and quality of kimchi [14].an open access article under the CC BY-NC-ND license (http://creativecommons.org/
Table 1
J Ethn Foods 2015; 2: 137e144138Over recent years, the consumer trend is toward commercial
kimchi. According to one report [15], over the past 7 years, the
amount of kimchi consumed in Korea has remained constant, but
the percentage accounted for by home-made kimchi has
decreased (64.6% in 2007 and 60.0% in 2013), whereas commer-
cial kimchi consumption has increased (35.3% in 2007 and 40.0%
in 2013). Owing to the expanding commercial market, studies on
kimchi-related probiotics and starter cultures have resulted in the
development of commercial kimchis with added vegetables and
in the use of lactic acid bacteria strains as a starter, such as Leu.
meseteroides, Leu. citreum, or Lactobacillus plantarum, with con-
stant quality, enhanced tastes, and health-promoting beneﬁts.
Obesity, which is a component of metabolic syndrome, is asso-
ciated with excess energy intake and low energy expenditure, and
is characterized by weight gain, type 2 diabetes, hypertension,
nonalcoholic fatty liver, glucose intolerance, inﬂammatory
response, and coronary heart disease and cancer development
associated with insulin resistance [16]. Obesity rates continue to
increase worldwide and now exceed 30% in Mexico, New Zealand,
and the United States. Thus, obesity is a major health problem
worldwide [17].
The basic molecular imbalance driving obesity is that between
lipogenesis and lipolysis. These processes are regulated in the liver
and adipose tissues by multienzyme systems, such as CCAAT/
enhance-binding protein-a (C/EBP-a), sterol regulatory element-
binding protein-1c (SREBP-1c), peroxisome proliferator-activated
receptor-g (PPAR-g), fatty acid synthase (FAS), and carnitine
palmitoyltransferase-1 (CPT-1) [18,19].
Some drugs used to treat clinical obesity are associated with
adverse effects such as nausea, insomnia, constipation, gastroin-
testinal problems, and potential adverse cardiovascular effects [20].
Therefore, efforts are being made to ﬁnd and develop antiobesity
foods and food ingredients that effectively reduce body fat accu-
mulation, reduce the risk of obesity-related chronic diseases, and
minimize the side effects in clinical treatment [21,22].
The present study was designed to investigate the antiobesity
activities of home-made and commercial kimchi (containing Leu.
mesenteroides DRC 0211 as starter and several subingredients) in
high-fat DIO mice, by determining weight loss effects after 4 weeks
of obesity induction, followed by 4 weeks of kimchi administration.
In addition, mechanisms responsible for their antiobesity effects
were also investigated.Compositions of experimental diets used in the animal study.
Ingredient (g/1,000 g diet) Experimental diet
HFD S-Kimchi D-Kimchi
Casein 245 220.5 220.5
L-Cystine 3.5 3.15 3.15
Corn starch 85 76.5 76.5
Maltodextrin 115 103.5 103.5
Sucrose 200 180 180
Cellulose 58 52.2 52.2
Soybean oil 30 27 27
Lard 195 175.5 175.5
Mineral mix, AIN-93G-MX 43 38.7 38.7
Calcium phosphate, dibasic 3.4 3.06 3.06
Vitamin mix, AIN-93-VX 19 17.1 17.1
Choline bitartrate 3 2.7 2.7
Red food color 0.1 0.09 0.09
S-Kimchi d 100 d
D-Kimchi d d 100
Calories (kcal) 4,659 4,659 4,659
The ND group received ND (AIN-93G diet), the HFD group received a high-fat diet for
8 weeks, the S-Kimchi group received an HFD for 4 weeks followed by the same HFD
containing 10% standard kimchi for 4 weeks, and the D-Kimchi group received the
HFD for 4 weeks and HFD containing 10% commercial D-Kimchi for the next 4
weeks.
D-Kimchi, Korean commercial kimchi; HFD, high-fat diet; ND, normal diet; S-Kimchi,
standardized kimchi.2. Materials and methods
2.1. Sample preparation
Standardized kimchi (S-Kimchi) was developed by the Kimchi
Research Institute at Pusan National University (Busan, Korea), and
prepared using the following ingredients: 13.0 g radish, 2.0 g green
onion, 3.5 g red pepper powder, 1.4 g garlic, 0.6 g ginger, 2.2 g an-
chovy juice, and 1.0 g sugar, in 100 g of brined baechu cabbage [23].
A Korean commercial kimchi manufactured by Daesang FNF (D-
Kimchi; Icheon, Korea), which was the most consumed commercial
kimchi in 2012 [24], was used in the present study. D-Kimchi is
prepared using the following ingredients: 18.0 g radish, 3.5 g red
pepper powder, 3.8 g garlic, 0.5 g ginger, 2.5 g leek (Allium tuber-
osum), 1.5 g green onion, 3.5 g anchovy juice, 3 g sea tangle extract,
and 8 g rice starch in 100 g of brined baechu cabbage; it was
inoculated with 106 colony-forming units/g Leu. mesenteroides DRC
0211.
Kimchi samples were fermented at 4C until pH values reached
4.3 (optimum for the ripened state) and then freeze-dried to pre-
pare the experimental diets.2.2. Animals and treatment
Male C57BL/6J mice (6-week old, 18 ± 0.5 g) were purchased
from Samtako Bio Korea (Osan, Korea) and housed under standard
conditions (50e60% relative humidity, under a 12-hour dark/12-
hour light cycle). Food and water were supplied ad libitum.
Animals were randomly divided into four groups of eight mice
each: the ND group was administered a normal diet (ND; AIN-93G
diet) for 8 weeks; the HFD group was provided a high-fat diet (HFD;
45% lard oil in AIN-93G diet) for 8 weeks, and the S- and D-Kimchi
groups were fed the HFD diet for the ﬁrst 4 weeks and the HFD diet
containing 10% of freeze-dried S-Kimchi or D-Kimchi, respectively,
for the remaining 4 weeks. Compositions of the experimental diets
are provided in Table 1.
Body weights and food intakes were checked weekly, and ani-
mals were sacriﬁced on the last day of the 8-week experimental
period. The protocol used in this study was approved by the Insti-
tutional Animal Care and Use Committee of Pusan National Uni-
versity (PNU-IACUC) (approval number PNU-2013-0455).
2.3. Serum and tissue preparation
At the end of the experiment, blood samples were collected
from the inferior vena cava of each animal. Serum was separated
from blood by centrifugation at 3,000g for 10 minutes at 4C. Or-
gans of interest, that is, liver, epididymal fat, and perirenal fat tis-
sues, were surgically removed immediately, washed with cold
normal saline, wiped with a paper towel, and weighed. Serum and
organ samples were stored at 80C for further study.
2.4. Serum lipid, insulin, leptin, and adiponectin analysis
Serum levels of triglyceride (TG), total cholesterol (TC), high-
density lipoprotein-cholesterol (HDL-c), and low-density lipopro-
tein-cholesterol (LDL-c) were measured using a commercial kit
(Asan Pharmaceutical Co., Seoul, Korea), and serum levels of insu-
lin, leptin, and adiponectin were measured using a commercial
enzyme-linked immunosorbent assay kit (R&D System, Minneap-
olis, MN, USA).
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The liver and epididymal fat tissues were subjected to histo-
logical examinations. Tissues were ﬁxed in 10% (v/v) neutral buff-
ered formalin, dehydrated in ethanol, and embedded in parafﬁn.
Sections (4 mm) were then prepared and stained with hematoxylin
and eosin. Images were developed using a Zeiss Axioskop 2 Plus
microscope equipped with an AxioCam MRc5 CCD Camera (Carl
Zeiss MicroImaging, Thornwood, NY, USA).
2.6. Reverse transcription polymerase chain reaction assays
The mRNA expressions of C/EBP-a, SREBP-1c, PPAR-g, CPT-1,
FAS, monocyte chemotactic protein-1 (MCP-1), and interleukin-6
(IL-6) were determined by reverse transcription polymerase chain
reaction (PCR). TRIzol, oligo dT12e18 primer, reverse transcriptase
buffer, deoxyribonucleotide triphosphates (dNTPs), murine Malo-
ney leukemia virus reverse transcriptase, RNase inhibitor, and
agarose were obtained from Invitrogen Life Technologies (Carlsbad,
CA, USA). All were of analytical grade.
Total RNA was isolated using TRIzol reagent, according to the
manufacturer's instructions. Brieﬂy, 200 mL of chloroform was
added to the liquid phase separated from tissue sample and
centrifuged at 12,000g for 15 minutes at 25C. Isopropanol was
then added to supernatants at a 1:1 (v:v) ratio and RNA was pel-
leted by centrifugation (12,000g for 15 minutes at 4C). After
washing the pellets with 70% ethanol, the RNA was solubilized in
diethyl pyrocarbonate-treated RNase-free water and quantiﬁed by
measuring absorbance at 260 nm using a UV-2401PC spectropho-
tometer (Shimadzu, Kyoto, Japan). Equal amounts of RNA (1 mg)
were then reverse transcribed in an AccuPower PCR PreMix (Bio-
neer, Daejeon, Korea) containing 1 reverse transcriptase buffer,
1mM dNTPs, 500 ng of oligo dT18 primers, 140 U of murineMaloney
leukemia virus reverse transcriptase, and 40 U of RNase inhibitor
for 45 minutes at 42C. PCR was then carried out in an automatic
PCR thermocycler (Bioneer). PCR products obtained were separated
in 2% agarose gels and visualized by ethidium bromide staining.
Glyceraldehyde-3-phosphate dehydrogenase was used for
normalization.
2.7. Statistical analysis
Results are presented as means ± standard deviations. The sig-
niﬁcances of differences between group mean values were deter-
mined by one-way analysis of variance and Duncan's multiple
range test. A value of p < 0.05 was considered statistically signiﬁ-
cant. SPSS v18.0 statistical software (SPSS Institute Inc., Chicago, IL,
USA) was used to conduct the analysis.Table 2
Body weights, food intakes, food efﬁciency ratios, and tissue weights in DIO mice.
ND
Body weight (g) Initial 23.4 ± 1.3 (NS)
4th wk 24.7 ± 0.9* (1.3)y
8th wk 27.2 ± 1.2x (2.5)k
Body weight gain (g/d) 0.1 ± 0.1*
Food intake (g/d) 3.4 ± 0.1 (NS)
Food efﬁciency ratio (%)¶ 2.7 ± 0.8*
Group deﬁnitions are detailed in the legend of Table 1.
Results are presented as means ± SDs.
DIO, diet-induced obese; D-Kimchi, Korean commercial kimchi; HFD, high-fat diet; ND, no
*,z,x Means with different letters in the same row are signiﬁcantly different (p < 0.05) by
y Grams of body weight gained during the ﬁrst 4 weeks of the experimental period.
k Grams of body weight gained during the second 4 weeks (after the 8-week experim
¶ Food efﬁciency ratio ¼ total weight gain/total food intake.3. Results
3.1. Effects of kimchis on body weights, food intakes, food efﬁciency
ratios, and tissue weights
Initial body weights in the four study groups were similar.
However, after the ﬁrst four experimental weeks, the mean body
weights in groups fed HFD, that is, the HFD, S-Kimchi, and D-Kimchi
groups, were markedly higher than that of the ND group
(29.5 ± 1.1 g, 29.1 ± 0.7 g, and 29.3 ± 0.7 g, respectively, vs.
24.7 ± 0.9 g) (Table 2). After the 8th week, the S- and D-Kimchi
groups had signiﬁcantly lower mean body weights than the HFD
group (32.8 ± 2.5 g and 32.6 ± 2.3 g, respectively, vs. 43.0 ± 3.4 g)
(p < 0.05). At this time, the ND group had a mean body weight of
27.2 ± 1.2 g. Summarizing, the mean body weight in the HFD group
increased by 14 g after the 8-week experimental period, whereas
the S- and D-Kimchi groups gained only 3 g, and the ND group
gained 2.5 g.
No signiﬁcant intergroup differences in food intake were
observed; however, the mean food efﬁciency ratios in the S-Kimchi
(3.9 ± 0.1%) and D-Kimchi (3.5 ± 0.5%) groups were signiﬁcantly
lower than that in the HFD group (13.9 ± 1.6%) (the mean food
efﬁciency ratio in the ND group was 2.7 ± 0.8%) (Table 2).
After the 8-week experimental period, themean liver weights in
the kimchi groups (1.5 ± 0.2 g and 1.5 ± 0.1 g for the S- and D-Kimchi
groups, respectively) were signiﬁcantly lower than that in the HFD
group (1.9 ± 0.5 g) (the mean liver weight in the ND group was
1.6 ± 0.1 g). Kimchi-treated groups showed signiﬁcantly lowermean
epididymal fat tissue weights (S-Kimchi group: 0.9 ± 0.4 g; D-
Kimchi group: 0.9 ± 0.6 g) and perirenal fat tissue weights (S-
Kimchi group: 0.5 ± 0.2 g; D-Kimchi group: 0.5 ± 0.3 g) than those
in the HFD group (epididymal fat: 2.3 ± 0.5 g; perirenal fat:
1.0 ± 0.3 g) (the mean epididymal and perirenal fat tissue weights
in the ND groupwere 0.4 ± 0.1 g and 0.1 ± 0.1 g, respectively; Fig. 1).
3.2. Effect of kimchi on serum lipid proﬁles
After the 8-week experimental period, HFD signiﬁcantly
increased serum levels of TG and TC in the HFD and S- and D-
Kimchi groups as compared with the ND group (Table 3). The ND
group (TG: 72.6 ± 4.7 mg/dL; TC: 85.1 ± 3.0 mg/dL) had the lowest
TG and TC levels, and the HFD group had the highest levels (TG:
161.1 ± 10.9 mg/dL; TC: 124.1 ± 6.2 mg/dL). Serum levels of these
markers in the S- and D-Kimchi groups were signiﬁcantly lower
than those in the HFD group, and the difference was greater for the
D-Kimchi group (87.6 ± 8.4 mg/dL of TG and 90.0 ± 6.7 mg/dL of TC
for the D-Kimchi group vs. 94.1 ± 9.3 mg/dL of TG and
104.4 ± 4.2 mg/dL of TC for the S-Kimchi group).HFD S-Kimchi D-Kimchi
23.3 ± 1.3 23.5 ± 0.6 23.4 ± 0.6
29.5 ± 1.1z (6.2) 29.1 ± 0.7z (5.6) 29.3 ± 0.7z (5.9)
43.0 ± 3.4z (13.5) 32.8 ± 2.5* (3.7) 32.6 ± 2.3* (3.3)
0.5 ± 0.1z 0.1 ± 0.1* 0.1 ± 0.1*
3.5 ± 0.2 3.4 ± 0.1 3.5 ± 0.1
13.9 ± 1.7z 3.9 ± 0.1* 3.5 ± 0.5*
rmal diet; NS, not signiﬁcant; SD, standard deviation; S-Kimchi, standardized kimchi.
Duncan's multiple range tests.
ental period).
Fig. 1. Tissue weights of liver, epididymal fat, and perirenal fat in DIO mice (after the 8-week experimental period). Results are presented as means ± SDs. Group deﬁnitions are
detailed in the legend of Table 1. *,y,z Means with different letters are signiﬁcantly different (p < 0.05) by Duncan's multiple range tests. DIO, diet-induced obese; D-Kimchi, Korean
commercial kimchi; HFD, high-fat diet; ND, normal diet; SD, standard deviation; S-Kimchi, standardized kimchi.
Table 3
Serum levels of TG, TC, HDL-c, and LDL-c in DIOmice (after the 8-week experimental
period).
Serum levels (mg/dL) Groups
ND HFD S-Kimchi D-Kimchi
TG 72.6 ± 4.7* 161.1 ± 10.9y 94.1 ± 9.3z 87.6 ± 8.4*,z
TC 85.1 ± 3.0x 124.1 ± 6.2y 104.4 ± 4.2y,z 90.0 ± 6.7*,x
LDL-c 9.8 ± 2.3* 50.8 ± 6.0y 39.7 ± 1.9z 17.3 ± 6.8*
HDL-c 60.8 ± 2.2y 41.4 ± 3.3z 45.8 ± 4.2z 55.2 ± 2.1y
Results are presented asmeans ± SDs. Group deﬁnitions are detailed in the legend of
Table 1.
*,y,zMeans with different letters in the same row are signiﬁcantly different (p < 0.05)
by Duncan's multiple range tests.
DIO, diet-induced obese; D-Kimchi, Korean commercial kimchi; HDL-c, high-density
lipoprotein-cholesterol; HFD, high-fat diet; LDL-c, low-density lipoprotein-
cholesterol; ND, normal diet; SD, standard deviation; S-Kimchi, standardized
kimchi; TC, total cholesterol; TG, triglyceride.
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(50.8 ± 6.0 mg/dL), followed by the S-Kimchi group (39.7 ± 1.9 mg/
dL), D-Kimchi group (17.3 ± 6.8 mg/dL), and ND group
(9.8 ± 2.3 mg/dL); the mean HDL-c level was low in the HFD group
(41.4 ± 3.3 mg/dL), but signiﬁcantly higher in the D-Kimchi group
(55.2 ± 2.1mg/dL) and higher in the S-Kimchi group (45.8 ± 4.2mg/
dL). At this time, the ND group had a mean LDL-c level of
60.8 ± 2.2 mg/dL.
3.3. Effect of kimchi on serum levels of insulin, leptin, and
adiponectin
At 8 weeks, the mean serum insulin level in the HFD group was
signiﬁcantly elevated (9.5 ± 0.1 mg/dL) as compared with that inFig. 2. Serum levels of insulin, adiponectin, and leptin in DIO mice after the 8-week experim
legend of Table 1. *,y,z,x Means with different letters are signiﬁcantly different (p < 0.05) by
kimchi; HFD, high-fat diet; ND, normal diet; SD, standard deviation; S-Kimchi, standardizedthe S-Kimchi (7.2 ± 0.2 mg/dL), D-Kimchi (6.7 ± 0.4 mg/dL), and ND
(6.1 ± 0.0 mg/dL) groups (p < 0.05).
The HFD group had the highest mean serum leptin level
(39.2 ± 1.4 mg/dL) after the experimental period. Values for the
other three groups were signiﬁcantly lower (S-Kimchi group:
21.7 ± 1.0 mg/dL; D-Kimchi group: 17.2 ± 0.7 mg/dL; and ND group:
13.3 ± 0.9 mg/dL).
In addition, the mean adiponectin level was signiﬁcantly higher
in the D-Kimchi group (33.3 ± 0.2 mg/dL) than that in the S-Kimchi
(31.7 ± 0.5 mg/dL) and HFD (29.0 ± 0.7 mg/dL) groups (the ND
group had a mean adiponectin level of 35.4 ± 0.6 mg/dL; Fig. 2).
3.4. Histological observations and mRNA expression of C/EBP-a,
PPAR-g, SREBP-1c, FAS, and CPT-1 in liver tissue
The hepatic histological study conducted after the 8-week
experimental period showed that kimchi treatment signiﬁcantly
reduced HFD-induced lipid formation in the liver (Fig. 3A). The
livers in the HFD group showed steatosis, characterized by
numerous large fat globules. However, in the kimchi-treated
groups, fat globules were obviously fewer and smaller. In particular,
the livers in the D-Kimchi group appeared near normal; no fat
globules were observed in the ND group.
Reverse transcription PCR was used to assess hepatic mRNA
expressions of adipogenesis (C/EBP-a, PPAR-g, SREBP-1c, and FAS)-
and fatty acid oxidation (CPT-1)-related genes. Interestingly, the D-
Kimchi group showed lower expressions of adipogenesis-related
factors than the S-Kimchi and HFD groups. In addition, kimchi
supplementation also increased the mRNA levels of CPT-1 (a rate-
limiting enzyme in the b-oxidation of fatty acids) as compared
with that in the HFD group (Fig. 3B).ental period. Results are presented as means ± SDs. Group deﬁnitions are detailed in the
Duncan's multiple range tests. DIO, diet-induced obese; D-Kimchi, Korean commercial
kimchi.
Fig. 3. Study of the liver tissues of DIO mice after the 8-week experimental period. (A) Histological observations. (B) The mRNA expressions of C/EBP-a, PPAR-g, SREBP-1c, FAS, and
CPT-1. The intensities of bands were measured by densitometry and are expressed as folds of the control (HFD) divided by GAPDH. Fold ratio: gene expression/GAPDH  control
numerical value (control fold ratio set at 1). Group deﬁnitions are detailed in the legend of Table 1. *,y,z,x Means with different letters are signiﬁcantly different (p < 0.05) by Duncan's
multiple range tests. C/EBP-a, CCAAT/enhance-binding protein-a; CPT-1, carnitine palmitoyltransferase-1; DIO, diet-induced obese; D-Kimchi, Korean commercial kimchi; FAS, fatty
acid synthase; GAPDH, glyceraldehyde-3-phosphate dehydrogenase; HFD, high-fat diet; ND, normal diet; PPAR-g, peroxisome proliferator-activated receptor-g; S-Kimchi, stan-
dardized kimchi; SREBP-1c, sterol regulatory element-binding protein-1c.
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tissues
Histological assays showed that kimchi administration reduced
HFD-induced fat accumulation in epididymal fat tissues (Fig. 4A).
Mean adipocyte sizes in epididymal fat were greater in the three
HFD-fed groups (especially in the HFD group) than in the ND group.
However, the mean adipocyte size in the D-Kimchi group (1.8 ± 0.7
units) was smaller than that in the HFD or S-Kimchi groups (HFD
group: 7.5 ± 2.6 units; S-Kimchi group: 3.4 ± 0.8 units), and was
similar to that of the ND group (2.0 ± 0.7 units).
Furthermore, the two kimchi-treated groups had signiﬁcantly
lower MCP-1 mRNA expressions (an important mediator of
macrophage activity and promoter of inﬂammatory response in
adipose tissues) and IL-6 expressions (an inﬂammatory cytokine) inepididymal fat tissues than the HFD group after the 8-week
experimental period (Fig. 4B).
4. Discussion
In the present study, we investigated the antiobesity activities of
home-made and commercial kimchi in Korea using a mouse model,
and checked biomarkers in serum and tissue samples.
During the ﬁrst 4 weeks of the experimental period, the weight
gains shown by mice in the HFD, S-Kimchi, and D-Kimchi groups
were similar. After the second 4 weeks, HFD group animals gained
13.5 g in body weight versus baseline, and the animals in the S-
Kimchi, D-Kimchi, and ND group gained 3.7 g, 3.3 g, and 2.5 g,
respectively. These ﬁgures are equal to body weight gains of only
0.1 ± 0.1 g/d in the S-Kimchi, D-Kimchi, and ND groups, but a
Fig. 4. Study of epididymal fat tissues of DIO mice (8th week). (A) Histological observations. (B) The mRNA expressions of MCP-1 and IL-6. The average sizes of adipocytes were
measured on histological slides using Image J (right panel). The intensities of bands were measured by densitometry and are expressed as folds of the control (HFD) divided by
GAPDH. Fold ratio: gene expression/GAPDH  control numerical value (control fold ratio set at 1). Group deﬁnitions are detailed in the legend of Table 1. *,y,z,x Means with different
letters are signiﬁcantly different (p < 0.05) by Duncan's multiple range tests. DIO, diet-induced obese; D-Kimchi, Korean commercial kimchi; GAPDH, glyceraldehyde-3-phosphate
dehydrogenase; HFD, high-fat diet; IL-6, interleukin-6; MCP-1, monocyte chemotactic protein-1; ND, normal diet; S-Kimchi, standardized kimchi.
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more, themean food efﬁciency ratios in the S- and D-Kimchi groups
(3.9 ± 0.1% and 3.5 ± 0.5%, respectively) and the ND group
(2.7 ± 0.8%) were signiﬁcantly lower than that in the HFD group
(13.9 ± 1.7%) (p < 0.05), which conﬁrms the body-weight-reducing
effect of kimchi. In addition, kimchi (S- and D-Kimchi) signiﬁcantly
reduced adipose tissueweights (epididymal fat and perirenal fat) as
compared with HFD alone (Fig. 1) (p < 0.05). The main subing-
redients of kimchi, that is, red pepper powder, garlic, and ginger,
have also been associated with signiﬁcant reductions in body
weight gain and fat mass in HFD-treated Sprague-Dawley (SD) rats
[25]. S- and D-Kimchi contain similar levels of subingredients;
however, D-Kimchi contains leeks and sea tangle, and is prepared
using an Leu. mesenteroides DRC 0211 starter. Recently, it was re-
ported that leeks have an antiobesity effect in vitro [26] and that
Leuconostoc sp. JC046 decreases body weights of mice fed an HFD
[27]. Thus, these subingredients might have affected the antiobe-
sity effect observed in this study.
Long-term consumption of an HFD causes an imbalance in
serum lipid proﬁles, as characterized by increased serum TG, TC,
and LDL-c levels and reduced HDL-c levels, and this imbalance is a
high risk factor of coronary heart disease and atherosclerosis [28].
In accordance with some other studies [26,29], we found that
kimchi signiﬁcantly reduced serum TG, TC, and LDL-c levels, and
increased serum HDL-c levels in high-fat DIO mice. In addition, D-Kimchi had signiﬁcantly greater effects on LDL-c and HDL-c levels
than S-Kimchi, which might have been associated with high levels
of Leu. mesenteroides, which is in accord with the serum-lipid-
controlling effect of Leuconostoc sp. in mice reported in another
study [27]. Therefore, our results suggest that the bacterial
composition in kimchi is related to the modulation of the serum
lipid proﬁle in DIO mice.
Adipose tissue releases adipocytokines, such as tumor necrosis
factor alpha, IL-6, leptin, and adiponectin [30], and elevated serum
leptin and depressed serum adiponectin levels are characteristic of
obesity [31]. In another study, long-term intake of an HFD induced
high levels of insulin in serum, caused insulin resistance, and
increased fat accumulation in the liver [32]. In the present study,
we found that kimchi decreased serum insulin and increased serum
adiponectin, an insulin sensitizer that might improve insulin
clearance and signiﬁcantly reduce fat accumulation in the livers of
DIO mice (Fig. 2). We also found that the two types of kimchi
studied signiﬁcantly reduced serum leptin levels and increased the
levels of adiponectin, which are associated with adipocyte hyper-
trophy [33] and reduced fat accumulations in epididymal fat tissues
(Figs. 2 and 4).
It is well known that the liver importantly regulates the accu-
mulation of adipose tissue and controls lipid levels in the blood
[34]. In previous studies, animals in the kimchi groups had lower
liver weights (Fig. 1), and their livers contained smaller and fewer
M. Cui et al / Antiobesity effects of kimchi 143lipid globules than animals in the HFD group (Fig. 3A). In particular,
animals in the HFD group showed severe steatosis and hepato-
megaly, but those in the kimchi groups had only moderate liver
steatosis and showed no hepatomegaly. These results suggest that
the administration of kimchi suppressed fat accumulation in the
liver and, thus, reduced body weight gains.
SREBP-1c is an important lipogenic transcription factor that
regulates the levels of fatty acid and TG by regulating the expres-
sion of FAS, a rate-limiting enzyme in the fatty acid pathway [35].
High levels of SREBP-1c induced by high HFD intake have also been
reported to upregulate the expression of FAS, resulting in lipo-
genesis in the liver and adipose tissue [35]. PPAR-g also enhances
the activity of C/EBP, an important regulator of preadipocyte dif-
ferentiation (C/EBP-b and C/EBP-d), and promotes adipogenesis (C/
EBP-a) [36]. In another study, reductions in PPAR-g activity effec-
tively decreased body weight gains and hepatic TG levels in mice
[37]. CPT-1 is a rate-limiting enzyme in b-oxidation of fatty acids
and is used as a marker of lipid degradation [38]. In the present
study, kimchi supplementation, particular D-Kimchi, signiﬁcantly
reduced hepatic mRNA levels of SREBP-1c, FAS, PPAR-g, and C/EBP-
a, and increased CPT-1 mRNA levels, indicating that kimchi sup-
pressed HFD-induced lipogenesis in DIO mice.
Obesity is associated with chronic systemic inﬂammation [39].
Elevated expressions of the mRNAs of tumor necrosis factor alpha,
IL-6, and MCP-1 have been observed in the adipose tissues of obese
mice [40], and in the present study, fat globules in epididymal fat
tissues of the HFD group animals were larger than those of the ND
group animals, whereas in kimchi supplement groups these were
similar in size to that observed in the ND group (p < 0.05). This
result suggests that kimchi reduced epididymal fat globule hyper-
trophy during the 4-week supplementation period. In addition, the
S- and D-Kimchi groups showed signiﬁcantly lower MCP-1 and IL-6
mRNA levels, and less macrophage inﬁltration into epididymal fat
tissue than the HFD group (p < 0.05). These results suggest that
kimchi has anti-inﬂammatory activity and positively reduces
obesity in DIO mice.
Summarizing, the present study demonstrates the antiobesity
effect of kimchi in a DIO mouse model. In this model, home-made
and commercial kimchi suppressed body weight gains and fat
accumulation in tissues, andmodulated serum lipid levels and lipid
metabolism-related genes in the liver and epididymal fat tissues.
These results suggest the possibility that subingredients, such as
leeks and starter (Leu. mesenteroides DRC 0211), enhance the anti-
obesity effect of kimchi. Furthermore, our results show that com-
mercial Korean kimchi can reduce body fat as well as home-made
kimchi.
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